Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Humacyte (HUMA) Gross Margin (2025)

Humacyte has reported Gross Margin over the past 1 years, most recently at 1844.75% for Q4 2025.

  • Quarterly results put Gross Margin at 1844.75% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 376.05% (changed N/A YoY), and the annual figure for FY2025 was 376.05%, changed.
  • Gross Margin for Q4 2025 was 1844.75% at Humacyte, down from 65.47% in the prior quarter.
  • Over the last five years, Gross Margin for HUMA hit a ceiling of 71.57% in Q1 2025 and a floor of 1844.75% in Q4 2025.